ESTATE: what a single-arm tirzepatide study can show
The retrospective ESTATE study examined twenty-four-week changes in eighty-eight Japanese adults with type 2 diabetes in routine practice.
Human physiology studyPaper year: 2026Tirzepatide
01 / DESIGN
What was studied?
The retrospective ESTATE study examined twenty-four-week changes in eighty-eight Japanese adults with type 2 diabetes in routine practice.
02 / FINDINGS
What did the researchers report?
Glycated hemoglobin and body-mass index decreased. Gastrointestinal symptoms were the main reported treatment-associated adverse events; exploratory satisfaction measures were also analyzed.
03 / INTERPRETATION
What are the limits?
Without a control group, baseline differences and concurrent care cannot be excluded. A retrospective association is not a comparison against other treatments or dosing strategies.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.
RESEARCH CONTEXT
These are original reading notes on published studies, not product testimonials. Clinical studies used their own pharmaceutical formulations and protocols; their findings do not establish the safety, efficacy or equivalence of materials in our catalog. No personal-use or treatment guidance is provided.
Related catalog navigation only. The supplied material is not established as equivalent to the study product, and the paper does not certify a supply batch.
